Hyosung Chemical

At a glance

Hyosung Chemical filed 79 disclosures in the last 12 months, including 4 earnings, 3 insider and 3 5% holder. The most recent key filing was on Oct 30: Operating profit: loss narrowed (-₩26.1B → -₩19.5B). Revenue ₩734B, up 26.4% YoY.

Revenue for 2025 was ₩2.34T, down 4.5% on 2024. It made an operating loss of ₩161B. Debt was 310% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩1.46T and operating profit of ₩171B.

The 2025 annual report lists 884 employees with an average tenure of 14.2 years and average pay of ₩92.5M, #219 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩171M each on average. It paid no cash dividend for 2025. ㈜효성 and related parties held 52.32% at year end.

From the 2025 annual report

Staff: 884 (778 men, 106 women), of whom 22 on fixed-term contracts. Total pay for the year: ₩82B. Directors and auditors: 5, paid ₩854M in total.

No cash dividend was paid for 2025.

Largest shareholder

㈜효성 holds 32.84%; with 12 related parties the group holds 52.32% of common shares at year end.

Auditor: 삼일회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary